The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

BIOX Corp closed at $0.68.

Shares have lost 2.86% over the last five days, but have gained 106.06% over the last year to date. This security has outperformed the S&P TSX by 49.19% during the last year.

Key company metrics

  • Trailing P/E11.36×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.06
Updated at previous session's close. Delayed by at least 15 minutes.

Latest Company News

    No News Results.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Total other revenue--------
Total revenue14162718
Gross profit-1-16-1
Total cost of revenue15172119
Total operating expense14182320
Selling / general / administrative1111
Research & development--0--0
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)00--0
Other operating expenses, total-2------
Operating income0-25-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-1-24-3
Income after tax-1-241
Income tax, total000-4
Net income-1-241
Total adjustments to net income--------
Net income before extra. items-1-241
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-241
Inc. avail. to common incl. extra. items-1-241
Diluted net income-1-241
Dilution adjustment--0----
Diluted weighted average shares46464646
Diluted EPS excluding extraordinary itemsvalue per share-0.02-
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.02-